MMedication Read More FDA panel weighs ban on fluoride tablets and drops for kidsJuly 25, 2025 The Food and Drug Administration (FDA) said it plans to ban fluoride tablets and drops, which have long…
BBusiness Read More As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middleJuly 25, 2025 Jennifer Hill Blair recognized the Cincinnati number on her buzzing phone and slipped out of the school meeting,…
MMedication Read More FDA upgrades recall for 160K bottles of commonly prescribed medicationJuly 24, 2025 WASHINGTON (WKRC) – The Food and Drug Administration (FDA) has upgraded a recall of commonly prescribed medication. The…
BBusiness Read More Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to marketJuly 22, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
MMental health Read More Within a year, RFK wants to help you treat depression with psychedelics, LSD and ecstasyJuly 21, 2025 For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should…
MMedication Read More Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New LawsuitJuly 19, 2025 A stockholder has filed a derivative lawsuit against the board of directors of Hims & Hers, the fast‑growing…
MMedication Read More New recall of injected penicillin may put gains against syphilis in perilJuly 16, 2025 Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting…
GGenetics Read More FDA Rejects CAPR’s Cell Therapy BLA for Genetic Disorder, Stock TanksJuly 15, 2025 Shares of Capricor Therapeutics CAPR tanked 33% on Friday after it announced that the FDA issued a complete…
BBusiness Read More Urgent recall of popular vegetable brand over listeria fearsJuly 13, 2025 By NOA HALFF FOR DAILYMAIL.COM Published: 17:43 BST, 13 July 2025 | Updated: 17:53 BST, 13 July 2025…
MMedication Read More FDA focuses attention on rejected drug decisionsJuly 11, 2025 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…